Ms. Drexler brings technical / engineering capabilities, coupled with business vision and entrepreneurial experience, to the executive suite and the board room. She has been an active board member for public and private medical device and diagnostics companies for over a decade. She currently sits on the boards of ResMed (RSMD:NYSE), Outset Medical (Nasdaq: OM), EBR Systems (ASX), VIDA Diagnostics (private) and Qoniq (private).
Ms. Drexler also has extensive management experience. She founded and ran Amira Medical until its sale to Roche Diabetes Care. She managed a variety of functions across the company at LifeScan and executed the sale of the company to Johnson & Johnson. Most recently, Ms. Drexler was the CEO of Sandstone Diagnostics, a life science tools company focused on increased access to high quality diagnostic testing that was sold to LabCorp.
Ms. Drexler was named Female Entrepreneur of the Year by the Stevie Awards, 2013, and Entrepreneurial Woman of the Year by Silicon Valley Women’s Fund, 2002. She was also named a Director of the Year in 2018 by Women’s Inc. Magazine.
In addition to her corporate board roles, Ms. Drexler is active in Astia (www.astia.com) and Springboard (www.sb.co), nonprofit organizations that support female entrepreneurs. She actively advises several additional early stage medical device and digital health companies.
A native of New Jersey, Ms. Drexler received her MBA from Stanford University and her BSE in Chemical Engineering from Princeton University. She and her husband Andy, a fellow Stanford MBA, reside in the greater Boston Area.
